Catalent Stocks List
Symbol | Grade | Name | % Change | |
---|---|---|---|---|
CTLT | B | Catalent, Inc. | 0.55 | |
XNCR | F | Xencor, Inc. | 1.92 |
Related Industries: Biotechnology Drug Manufacturers - Specialty & Generic
Symbol | Grade | Name | Weight | |
---|---|---|---|---|
MNA | B | IQ Merger Arbitrage ETF | 5.66 | |
THNR | D | Amplify Weight Loss Drug & Treatment ETF | 4.75 | |
IHE | B | iShares U.S. Pharmaceutical ETF | 4.17 | |
UTRN | B | Vesper US Large Cap Short-Term Reversal Strategy ETF | 4.02 | |
XPH | D | SPDR S&P Pharmaceuticals ETF | 3.92 |
Compare ETFs
Date | Stock | Title |
---|---|---|
Jul 1 | CTLT | 7 Stocks' Profit Growth Will Blow Past Nvidia's This Quarter |
- Catalent
Catalent, Inc. (Catalent Pharma Solutions) is a multinational corporation headquartered in Somerset, New Jersey. It is a global provider of delivery technologies, development, drug manufacturing, biologics, gene therapies and consumer health products. It employs more than 14,000 people, including approximately 2,400 scientists and technicians. In fiscal year 2019, it generated over $2.5 billion in annual revenue.Catalent was formed in April 2007 when affiliates of the Blackstone Group L.P. acquired the core of the pharmaceutical technologies and services (PTS) segment of Cardinal Health, Inc. Cardinal Health created PTS through a series of acquisitions starting with R.P. Scherer Corporation in 1998.In 2014, Catalent became a public company and is listed on the New York Stock Exchange.
Recent Comments
- TraderMike on Bollinger Band Squeeze
- TraderMike on Bollinger Band Squeeze
- OpenCat584 on Bollinger Band Squeeze
- Dr_Duru on Expansion Breakout
- TraderMike on New Scans: Strong, Oversold Stocks and Weak, Overbought Stocks
From the Blog
Featured Articles